Northwestern University: Parkinson Disease trials

The registry lists 13 Parkinson Disease studies with Northwestern University as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 2 4Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson'sRecruitingNCT04664634Phase 3
• Mild Cognitive Impairment and Endurance Exercise in Parkinson's DiseaseCompletedNCT03542474Not applicableResults posted
• Nilotinib in Parkinson's DiseaseCompletedNCT03205488Phase 2Results posted
• Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's DiseaseTerminatedNCT01652534Phase 3Results posted
• PharmacoMRI of Parkinson DiseaseCompletedNCT01528592Not applicableResults posted
• Light Therapy Treatment in Parkinson's Disease Patients With Daytime SomnolenceCompletedNCT01338649Not applicableResults posted
• Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson DiseaseCompletedNCT00909545Phase 2Results posted
• Parkinson's Disease Isradipine Safety StudyCompletedNCT00753636Phase 2Results posted
• Spoken Discourse Biomarker of PD Cognitive ImpairmentCompletedNCT05909163
• A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's DiseaseCompletedNCT05421832
• Study in Parkinson Disease of ExerciseActive, not recruitingNCT04284436Not applicable
• Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability StudyActive, not recruitingNCT03667404Phase 2
• Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's DiseaseTerminatedNCT01544465Not applicable